COMMUNIQUÉS West-GlobeNewswire

Tourmaline Bio to Showcase Two Poster Presentations at the 2024 Cardiometabolic Health Congress

11/10/2024 - 13:30

NEW YORK, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients [...]

Better Choice Company to Expand into Veterinary Medicine in 2025 Following the Acquisition of SRx Health

11/10/2024 - 13:30

TAMPA, Fla., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or “the Company”), a pet health and wellness company, today announced expansion plans into veterinary medicine in 2025 [...]

NMD Pharma to Present Data on its Skeletal Muscle Targeted Therapy for Rare Neuromuscular Diseases at the 2024 AANEM Annual Meeting

11/10/2024 - 13:00

NMD Pharma to Present Data on its Skeletal Muscle Targeted Therapy for Rare Neuromuscular Diseases at the 2024 AANEM Annual Meeting Aarhus, Denmark, 11 October 2024 – NMD Pharma A/S, a clinical-stage biotech company [...]

Sagimet Biosciences Announces Publication of Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 MASH in The Lancet Gastroenterology & Hepatology

11/10/2024 - 13:00

- Treatment with denifanstat achieved statistically significant and clinically meaningful improvements in disease activity, MASH resolution and fibrosis - - Results support advancement of denifanstat into Phase 3 [...]

Curia s’engage envers la norme de neutralité carbone « net zéro » de la SBTi

11/10/2024 - 12:01

Albany, New York, 11 oct. 2024 (GLOBE NEWSWIRE) -- Curia, une organisation de recherche, de développement et de fabrication sous contrat de première importance fait part ce jour de son engagement à réduire ses émissions [...]

Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial Runway

11/10/2024 - 12:00

Realigning resources to focus on clinical advancement of Selected TIL therapy Reducing employee headcount by approximately 60% Streamlining operations with cash runway expected to extend into 2Q 2026 SAN DIEGO, Oct. 11 [...]

Communiqué de presse : Sanofi en discussions pour céder une participation majoritaire dans Opella

11/10/2024 - 08:50

Sanofi en discussions pour céder une participation majoritaire dans Opella Paris, 11 octobre 2024 . Sanofi a annoncé aujourd'hui avoir entamé des négociations avec CD&R pour la cession potentielle d’une [...]

Press Release: Sanofi in discussions to sell a controlling stake in Opella

11/10/2024 - 08:30

Sanofi in discussions to sell a controlling stake in Opella Paris, October 11, 2024 . Sanofi today announces that the company has entered into negotiations with CD&R for the potential sale of a 50% controlling stake [...]

Communiqué de presse : Sanofi en discussions pour céder une participation majoritaire dans Opella

11/10/2024 - 08:30

Sanofi en discussions pour céder une participation majoritaire dans Opella Paris, 11 octobre 2024 . Sanofi a annoncé aujourd'hui avoir entamé des négociations avec CD&R pour la cession potentielle d’une [...]

NMD Pharma to Present Data on its Skeletal Muscle Targeted Therapy for Rare Neuromuscular Diseases at the 2024 AANEM Annual Meeting

11/10/2024 - 07:00

NMD Pharma to Present Data on its Skeletal Muscle Targeted Therapy for Rare Neuromuscular Diseases at the 2024 AANEM Annual Meeting Aarhus, Denmark, 11 October 2024 – NMD Pharma A/S, a clinical-stage biotech company [...]

Sandoz US launches generic paclitaxel in single-dose vial, further expanding US oncology portfolio

11/10/2024 - 07:00

MEDIA RELEASE First FDA-approved abbreviated new drug application (ANDA) to reference medicine Single-dose 100 mg vial for intravenous use, approved for metastatic breast cancer Launch expected to be near-term growth [...]

Crinetics Pharmaceuticals Announces October 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10/10/2024 - 22:40

SAN DIEGO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on October 10, 2024, the Compensation Committee of Crinetics’ Board of Directors granted non-qualified [...]

Procedure of the Annual General Meeting

10/10/2024 - 22:35

ANNOUNCEMENT NO. 277 10 October 2024 Procedure of the Annual General Meeting The Annual General Meeting of ChemoMetec A/S was held on 10 October 2024 at 5.30 p.m. at Nordsjællands KonferenceCenter. At the Annual General [...]

Codexis to Report Third Quarter 2024 Financial Results on October 31

10/10/2024 - 22:05

REDWOOD CITY, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced that it will report [...]

PacBio to Report Third Quarter 2024 Financial Results on November 7, 2024

10/10/2024 - 22:05

MENLO PARK, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its third quarter 2024 financial results on Thursday, November 7, [...]

QIAGEN expands automated liquid biopsy portfolio to enhance oncology, prenatal care and organ transplant applications

10/10/2024 - 22:05

Portfolio expansion reinforces QIAGEN’s leadership in automated solutions for non-invasive liquid biopsy applications combined with complete workflows // New ccfDNA Kit upgrade with urine protocol for use on EZ1 and 2 [...]

SELLAS Life Sciences to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

10/10/2024 - 22:05

NEW YORK, Oct. 10, 2024 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a [...]

Mercy Places First Commercial Eversense 365: The World’s First and Only 365-Day Continuous Glucose Monitor

10/10/2024 - 22:05

Senseonics’ Eversense 365 is approved in the US as an integrated continuous glucose monitoring (iCGM) system for people with Type 1 and Type 2 diabetes aged 18 and older Commercial launch by Ascensia Diabetes Care [...]

Sutro Biopharma Highlights Next-Generation ADC Innovation and Near-term Pipeline at Research Forum

10/10/2024 - 22:05

Proprietary cell-free platform enables the design of next-generation ADCs intended to broaden addressable patient populations STRO-004 (tissue factor ADC) preclinical data has demonstrated greater anti-tumor activity [...]